Add to my selection

LAMZEDE (velmanase alfa)

Medicine - Posted on Jan 10 2025

Active substance (DCI)

velmanase alfa

history (4)

12/11/24

LAMZEDE (velmanase alfa) - Alpha-mannosidosis

Summary of opinion Favourable opinion: for reimbursement in the non-hospital setting, for maintenance of reimbursement in th...

CAV :
54321

icône flèche
1/19/22

LAMZEDE (velmanase alfa)

Key points Favourable opinion for maintenance of reimbursement in the enzyme replacement therapy of non-neurological manifes...

CAV :
54321

icône flèche
12/12/18

LAMZEDE (velmanase alpha), enzyme

Moderate clinical benefit in non-neurological manifestations of mild to moderate alpha-mannosidosis and minor clinical added...

CAV :
54321

icône flèche

Technical information

ATC code

A16AB15

Manufacturer

CHIESI SA

Presentation

LAMZEDE 10 mg, poudre pour solution pour perfusion
1 flacon en verre de 10 mg (CIP : 34009 550 519 6 1)
1 flacon en verre de 10 mg (CIP : 34009 302 829 4 6)

All our publications

Congenital, genetic and rare diseases

Drug therapy

Metabolic diseases

Paediatrics

My account

You do not have a saved search

LAMZEDE (velmanase alfa)

LAMZEDE (velmanase alfa) - Alpha-mannosidosis

LAMZEDE (velmanase alfa)

LAMZEDE (velmanase alpha), enzyme

Follow us :